Asthma and Allergy News and Research

FDA Authorizes COVID-19 Vaccines for Children 6 Months and Older
Dupixent® (Dupilumab) Is Approved for the Treatment of Moderate-to-Severe Atopic Dermatitis in Children 6 Months to 5 Years
People With Mast Cell Activation Syndrome (MCAS) Can Tolerate COVID-19 Vaccines
Recall Alert: Jergens Ultra Healing Moisturizer Due to Bacterial Contamination
Recall Alert: ACON Laboratories "Flowflex" COVID-19 Antigen Rapid Tests
All Blog Posts in Asthma and Allergy News and Research

Please wait...